Unknown primary carcinoma in the Netherlands: decrease in incidence and survival times remain poor between 2000 and 2012 von Schroten-Loef, C., Verhoeven, R.H.A., de Hingh, I.H.J.T., van de Wouw, A.J., van Laarhoven, H.W.M., Lemmens, V.E.P.P.

Volltext

Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984–1992 von van de Wouw, A.J, Janssen-Heijnen, M.L.G, Coebergh, J.W.W, Hillen, H.F.P

Volltext

The unknown biology of the unknown primary tumour: a literature review von van de Wouw, A. J., Jansen, R. L. H., Speel, E. J. M., Hillen, H. F. P.

Volltext

Abstract P3-13-11: Unexpected large treatment and outcome variations in metastatic breast cancer: Results of a hormone receptor positive cohort study in the Netherlands von Tjan-Heijnen, VCG, Lobbezoo, DJA, van Kampen, RJW, Voogd, AC, Dercksen, M, van den Berkmortel, F, Smilde, TJ, van de Wouw, AJ, Peters, FPJ, van Riel, JMGH, Peters, NAJB, de Boer, M, Peer, PGM

Volltext

Clinical and Immunohistochemical Analysis of Patients with Unknown Primary Tumour. A Search for Prognostic Factors in UPT von DE WOUW, Agnès J, JANSEN, Rob L. H, GRIFFIOEN, Arjan W, HILLEN, Harry F. P

Volltext

Decision aids for second-line palliative chemotherapy: a randomised phase II multicentre trial von Oostendorp, LJM, Ottevanger, PB, Donders, ART, van de Wouw, AJ, Schoenaker, IJH, Smilde, TJ, van der Graaf, WTA, Stalmeier, PFM

Volltext bestellen

Patients' Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist's Awareness of These Preferences von Oostendorp, LJM, Ottevanger, PB, van de Wouw, AJ, Honkoop, AH, Los, M, van der Graaf, WTA, Stalmeier, PFM

Volltext bestellen

Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study von Hoogerwaard, EM, Bakker, E, Ippel, PF, Oosterwijk, JC, Majoor-Krakauer, DF, Leschot, NJ, Van Essen, AJ, Brunner, HG, van der Wouw, PA, Wilde, AAM, de Visser, M

Volltext

Expected survival with and without second-line palliative chemotherapy: who wants to know? von Oostendorp, LJM, Ottevanger, PB, Van der Wouw, AJ, Schoenaker, IJH, De Graaf, H, Van der Graaf, WTA, Stalmeier, PFM

Volltext bestellen